Manufacturer record
JMH Pharma: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by JMH Pharma (Uttarakhand) was declared Not of Standard Quality in July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: JPC-3100, Deomax-LB (Amoxycillin. Cloxaeillin & Lactic Acid Closacillin & Lacne Acd Bacillus Capsules (exp Sep 2026). Gov Analyst Analyst. Haryana Chandigarh (state lab) found it not of standard quality: The sample does not pass the Assay of Anhy drous Amoxycillin & Cloxacillin per capsule is 10.86 mg & 67.73 mg against the claimed 250 mg. Listed in the July 2026 alert.
Records by type
1 record linked to JMH Pharma in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Deomax-LB (Amoxycillin. Cloxaeillin & Lactic Acid Closacillin & Lacne Acd Bacillus Capsules | Batch JPC-3100Mfg Oct 2024 · Exp Sep 2026 | The sample does not pass the Assay of Anhy drous Amoxycillin & Cloxacillin per capsule is 10.86 mg & 67.73 mg against the claimed 250 mg.Assay | Gov Analyst Analyst. Haryana ChandigarhState lab | Jul 2026 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.